In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Proligo and Exiqon Collaborate to Commercialize High Performance LNA Nucleic Acid Technology
EXIQON LICENSES LOCKED NUCLEIC ACIDS FOR SIRNA TO APPLIED BIOSYSTEMS
Proligo and RNAx Announce Collaboration in the Area of RNAi
Sigma-Aldrich Completes Acquisition of Proligo Group
Sigma-Aldrich to Acquire Proligo Group to Strengthen Genomics Research Tools Portfolio
Exiqon and Phoenix BioTechnologies sign license agreement
Proligo and Inex to launch genetic medicines manufacturing business
EXIQON TO ACQUIRE ONCOTECH INC AND ENTER THE MARKET FOR CANCER MOLECULAR DIAGNOSTICS IN 2008